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Abstract
The development of morphological neuronal polarity starts by the formation and elongation of an axon. At the same time
the axon initial segment (AIS) is generated and creates a diffusion barrier which differentiate axon and somatodendritic
compartment. Different structural and functional proteins that contribute to the generation of neuronal action potential are
concentrated at the axon initial segment. While axonal elongation is controlled by signalling pathways that regulate
cytoskeleton through microtubule associated proteins and tubulin modifications, the microtubule cytoskeleton under the
AIS is mostly unknown. Thus, understanding which proteins modify tubulin, where in the neuron and at which
developmental stage is crucial to understanding how morphological and functional neuronal polarity is achieved. In this
study performed in mice and using a well established model of murine cultured hippocampal neurons, we report that the
tubulin deacetylase HDAC6 is localized at the distal region of the axon, and its inhibition with TSA or tubacin slows down
axonal growth. Suppression of HDAC6 expression with HDAC6 shRNAs or expression of a non-active mutant of HDAC6 also
reduces axonal length. Furthermore, HDAC6 inhibition or suppression avoids the concentration of ankyrinG and sodium
channels at the axon initial segment (AIS). Moreover, treatment of mouse cultured hippocampal neurons with detergents to
eliminate the soluble pool of microtubules identified a pool of detergent resistant acetylated microtubules at the AIS, not
present at the rest of the axon. Inhibition or suppression of HDAC6 increases acetylation all along the axon and disrupts the
specificity of AIS cytoskeleton, modifying the axonal distal gradient localization of KIF5C to a somatodendritic and axonal
localization. In conclusion, our results reveal a new role of HDAC6 tubulin deacetylase as a regulator of microtubule
characteristics in the axon distal region where axonal elongation takes place, and allowing the development of acetylated
microtubules microdomains where HDAC6 is not concentrated, such as the axon initial segment.
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Introduction
The formation of the axon is the first step for a neuron to adopt
its morphological and functional polarization. Axon growth and
elongation depends, among other factors, on microtubules
polymerization, which is controlled by microtubule associated
proteins (MAPs), proteins that incorporate tubulin for polymeri-
zation, such as CRMP-2, and tubulin post-translational modifica-
tions (PTMs)[1]. While MAPs have been extensively studied, the
role and participation of PTMs in axonal growth is largely
unknown in neurons. Post-translational modifications of tubulin
affect mainly the C-terminus of tubulin and include tyrosination,
detyrosination, polyglutamylation, polyglycylation or D2 modifi-
cation, [2,3,4]. The only PTM not related with the C-terminus is
the acetylation of a-tubulin in lysine 40. The enzyme responsible
for this acetylation has not been characterized, but it was recently
proposed that Elp3, part of the elongator complex, may acetylate
a-tubulin [5]. The levels of a-tubulin acetylation are higher in
axon during its initiation [6] and during axonal elongation
different tubulin PTMs show a differential localization pattern
[7,8]. Detyrosinated (Glu-tubulin) and/or acetylated tubulin are
more resistant to depolymerizating agents and are the more stable
microtubules [9]. Moreover, PTMs such as tubulin acetylation,
alone or in combination with other PTMs, could have other
specific functions not related to microtubule stability. For example,
the molecular motor kinesin-1 binds preferentially to detyrosinated
and acetylated microtubules [10,11,12], and two of the members
of kinesin-1 family, KIF5C and KIF5B, have been identified at the
axon during initial axon formation and at the axon initial segment
[13,14]. The axon initial segment (AIS) develops from the very
beginning of axon formation [15], generates action potentials and
filters axonal transport [16,17,18]. How this specialized domain is
generated is poorly understood, however, treatment of neurons
with taxol, which increases tubulin acetylation, can disrupt axonal
polarized traffic [14]. Thus, together with the enrichment of
acetylated tubulin at the axon, the axon cytoskeleton needs
dynamic microtubules for its elongation and the specification of
axonal domains and polarized cargo transport. This change in
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microtubules requires the participation of enzymes that reverse
tubulin modifications, such as acetylation. Two enzymes that
catalyze a-tubulin deacetylation have been characterized; HDAC6
and SIRT2 [19,20]. Regarding nervous system, SIRT2 expression
has been detected in neurite growth cones and in oligodendrocytes
and plays a negative role in neurite growth in hippocampal
neurons [21,22]. On the other hand, HDAC6 expression has only
been detected in neurons [22], is able to regulate dendritic growth
[23], and its expression levels are reduced in mood disorder [24].
In non-neuronal cells, HDAC6 regulate microtubule growth
velocity [25], localizes to the motile structures of polarized cells
[26], is associated to the formation of cilia [27], participates in the
regulation of actin structures [28] and deacetylates cortactin [28]
and hsp90 [26]. In NIH 3T3 cells, HDAC6 controls the stability of
the dynamic pool of microtubules, and HDAC6 inhibition with
trichostatin A (TSA) delays their depolymerization [29], whereas
HDAC6 overexpression increases the chemotactic motility [19].
Moreover, HDAC6 interacts with and control the phosphorylation
of Tau [30], and it co-immunoprecipitates with the microtubule
end-tracking protein EB1 [25].
The objective of our study was to determine the possible role of
HDAC6 in axonal elongation and axon maturation, reflected in
the establishment of the axon initial segment in cultured
hippocampal neurons. We show that HDAC6 activity is necessary
to maintain axonal growth rate and also for the polarized
localization of proteins to the axon initial segment, which is
enriched in detergent resistant acetylated tubulin microtubules.
The lack of HDAC6 activity reduces axonal length, due to a lower
axonal growth rate, and delocalizes ankyrinG and voltage gated
sodium channels from the AIS. Our results suggest that the
impaired concentration of axon initial segment proteins is due to
the lost of AIS microtubules specificity when HDAC6 function is
suppressed. These changes in microtubules are reflected by the
alteration of KIF5C distribution along the neuron. Thus, HDAC6
play an important regulatory role in axonal elongation and also in
the establishment of functional neuronal polarity.
Materials and Methods
Cell culture
Mice were obtained from the Centro de Biologı´a Molecular and
treated following the guidelines of Council of Europe Convention
ETS123, recently revised as indicated in the Directive 86/609/
EEC. In addition all protocols were approved by the institutional
animal care and use committee. Hippocampal neurons were
prepared as described previously [31]. Briefly, the hippocampi
were obtained from E17 mouse embryos, washed in Ca2+/Mg2+-
free HBSS, digested with 0.25% trypsin for 15 minutes at 37uC and
dissociated. The cells were counted, diluted in MEM, 10% horse
serum, 0.6% glucose, and plated on polylysine coated coverslips
(1 mg/ml) at a density of 5,000 cells/cm2. Medium was changed
after 2 hours for Neurobasal containing B-27 and glutamax-I and
the neurons were cultured for 2 or more days. 5 mM 1-b-D-
arabinofuranosylcytosine (AraC) was added after two days in
culture. For biochemical experiments, hippocampal neurons were
plated at a density of 200,000 cells/cm2, and cultured for 48 hours.
Murine neuroblastoma N2a cells were originally obtained from the
American Type Cell Culture (Neuro-2A, Reference: CCL131) and
were grown at 37uC in 7% CO2, in DMEM supplemented with
10% foetal bovine serum (FBS, Invitrogen) and 2 mM glutamine.
Reagents and Plasmids
The plasmids used for transient expression were: HDAC6-Flag
(Addgene), HDAC6-GFP and HDAC6-H216A/H611A-GFP were
obtained from Dr. Sanchez-Madrid [32], pEGFP-N1 (Clontech),
shRNAs-HDAC6, and scramble shRNA in pGFP-V-RS vector
(Origene). N6,29-o-dibutyryladenosine 39,59-cyclic monophosphate
sodium (dibutyryl-cAMP) were from Sigma. Tubacin and niltubacin
were kindly provided by Dr. Ralph Mazitschek.
Cell Transfection
N2a cells were transfected using Lipofectamine 2000 (Invitro-
gen) according to the manufacturer’s instructions. For transfection,
500,000 cells were plated on a 60 mm-culture dish or on
polylysine-coated coverslips (1 mg/ml). Co-transfections were
performed with 9 ml Lipofectamine 2000 and 3 mg of total-
DNA. After 5 hours, the medium was change to DMEM without
FBS. N2a cells were induced to grow neurites by exposure to
1 mM dibutyryl-cAMP for 24 h in DMEM without FBS.
Primary hippocampal neurons were nucleofected using the
Amaxa nucleofector kit for primary mammalian neural cells
(Amaxa Bioscience) according to the manufacturer’s instructions.
Nucleofection was performed using 3 mg of total DNA. We used
36106 cells for each nucleofection and the cells were seeded at the
density of 56105 cells/cm2. Nucleofected neurons were analyzed
after 3 days in culture.
Detergent extraction of hippocampal neurons
For detergent extractions, neurons were left in culture for 5 DIV
and they were then treated with TSA. After 48 hours, the cells
were washed briefly in phosphate buffer before extracting the cells
with 0.5% Triton X-100 in cytoskeletal buffer (2 mM MgCl2,
10 mM EGTA, 60 mM Pipes pH 7.0) for 5 min at 37uC, as
described previously [18]. After extraction the neurons were rinsed
and fixed in PFA 4%. To analyze by Western-blot the acetylation
levels of polymerized tubulin, neurons were rinsed once with
sodium phosphate buffered saline (PBS) and once with PHEM
buffer (60 mM PIPES, 25 mM HEPES, 10 mM EGTA, 2 mM
MgCl2 [pH 6.9]) and they were then extracted for 5 min with
PHEM buffer containing 10 mM taxol, protease inhibitors, 0.1%
dimethyl sulfoxide and 0.2% Triton X-100 [33]. Extracted cells
were then lysed and homogenized in a buffer containing 20 mM
HEPES [pH 7.4], 100 mM NaCl, 100 mM NaF, 1% Triton X-
100, 1 mM sodium orthovanadate, 10 mM EDTA and Complete
inhibitor protease cocktail (Roche Diagnostics).
Immunocytochemistry
Neurons were fixed in 4% paraformaldehyde for 20 minutes
and washed in PBS. For immunodetection, the coverslips were
treated with 50 mM NH4Cl and incubated in blocking buffer
(0.22% gelatin, 0.1% Triton X-100 in PBS) to avoid non-specific
binding. The cells were then incubated for 1 hour at room
temperature with the primary antibodies diluted in blocking
buffer. The primary antibodies used were: mouse anti-acetylated-
a-tubulin (1:2000), mouse anti-tyrosinated-a-tubulin (1:2000),
mouse anti-MAP2 (1:400) and mouse anti-PanNaCh (1:75) from
Sigma; mouse anti-tau-1 (1:1000); and rabbit anti-MAP2 (1:500)
from Chemicon; mouse anti-ankyrinG (1:100) from Invitrogen;
rabbit anti-HDAC6 (1:400) and rabbit anti-KIF5C (1:200) from
Abcam. The secondary antibodies used were a donkey anti-mouse
or anti-rabbit Alexa-Fluor-488, 594 or 647 (1:500). F-actin was
stained using Alexa-Fluor-594-conjugated Phalloidin (1:100). After
staining, the coverslips were mounted with Fluoromount-G
(Southern-Biotech) and the images were acquired on a vertical
Axioskop-2plus microscope (Zeiss) or a confocal microscope
(LSM510, Zeiss) under the same conditions to compare intensities.
Differential interference contrast (DIC) images were obtained in a
LSM510 confocal microscope. Analysis of axon and dendrite
HDAC6 and Axon Development
PLoS ONE | www.plosone.org 2 September 2010 | Volume 5 | Issue 9 | e12908
length and fluorescence intensities was performed with the Neuron
J and ImageJ software tools. Images were prepared for
presentation using the Adobe CS3 software.
Western blot analysis
Protein samples were prepared from high density hippocampal
neuron cultures or murine neuroblastoma N2a. The cells were
lysed and homogenized in a buffer containing 20 mM HEPES
[pH 7.4], 100 mM NaCl, 100 mM NaF, 1% Triton X-100,
1 mM sodium orthovanadate, 10 mM EDTA and Complete
inhibitor protease cocktail (Roche Diagnostics). The proteins were
then separated on 8% SDS-PAGE gels and transferred to
nitrocellulose membranes. The membranes were incubated
overnight at 4uC with primary antibodies in blocking solution
(PBS, 0.2% Tween, 5% non-fat milk or 10% FBS). The antibodies
used to probe the membranes were: mouse anti-a-tubulin
(1:10.000), mouse anti-acetylated-a-tubulin (1:10.000), mouse
anti-b-actin (1:10.000), rabbit anti-Flag M2 (1:200, Sigma), mouse
anti-PanNaCh (1:200, Sigma) and rabbit anti-HDAC6 (1:200,
Santa Cruz Biotechnology) or rabbit anti-HDAC6 (1:200,
Abcam). Secondary antibodies were from Amersham. Antibody
binding was then visualized by ECL (Amersham) and densitom-
etry was performed with an imaging densitometer (GS-800, Bio-
Rad).
Statistical Analysis
All experiments were repeated at least three times and the
results are presented as the mean and standard error of the mean
(S.E.M). The number of neurons analyzed in each set of data is
indicated in figure legends. Statistical differences between
experimental conditions were analyzed by a t-test or paired t-test
using the Sigmaplot 9.0 software.
Results
Tubulin deacetylases inhibition reduces axonal
elongation
To assess whether tubulin deacetylases play a role in axonal
growth, cultured hippocampal neurons were treated with
trichostatin A (TSA), which inhibit HDACs but not sirtuins.
Treatment of neurons with 100 or 200 nM TSA for 2 DIV
increased tubulin acetylation (Figure S1). Control neurons showed
an acetylated tubulin staining along the axon with an increasing
distal gradient, while TSA treatment disrupted this polarization
and increased tubulin acetylation all along the neuron, both in the
axon and in the somatodendritic domain (Figure S1). Thus, we
assessed whether tubulin acetylation due to HDACs inhibition was
affecting axon initial specification or only axonal growth. TSA was
added to cultured hippocampal neurons 5 hours after plating,
before axon is specified, at a concentration of 100 or 200 nM and
kept for 48 hours (Figure 1A). As shown in figure 1B, only
43.4464.76% or 29.2862.95% of the neurons treated with 100 or
200 nM TSA, respectively, were able to develop an axon (a tau-1
positive process) when compared to control neurons
(78.3762.08%). Next, 2 DIV neurons (that have developed an
axon) were exposed to TSA until 4 DIV (Figure 1A). While control
neurons developed axons of 310.57613.48 mm, the length of the
axon developed by neurons treated with 100 nM or 200 nM TSA
was 151.85622.85 mm and 126.0160.29 mm, respectively
(Figure 1C).
Then we analyzed the expression of HDAC6, the only HDAC
specifically related with tubulin deacetylation. The antibody used for
immunocytochemistry was first analyzed for its HDAC6 specificity
in culture hippocampal neurons extracts or in extracts of N2a cells
expressing human HDAC6-Flag (Figure 2E). The antibody
specifically detects both the mouse and the human HDAC6 proteins,
and colocalizes with HDAC6-GFP expression in neurons (Figure
S3). When we analyzed the expression of HDAC6 during axon
elongation, HDAC6 was detected in the incipient axon of 1.5 DIV
neurons, while its expression was mainly located to the distal axon in
3 and 4 DIV neurons, co-localizing with tau-1 in neurons with a
longer axon (Figure 2A and B). Also, in a model of neurons with
multiple axons, such as cytochalasin D treatment, HDAC6 was
detected in all processes following the same pattern that tau-1
(Figure 2D). Even more, HDAC6 expression was co-localized with
acetylated-a-tubulin, its putative substrate (Figure 2C).
Figure 1. Inhibition of Tubulin deacetylases impairs axon
elongation. (A) 2 DIV hippocampal neurons cultured for 48 hours in
the presence or absence of TSA (100 nM), and 4 DIV hippocampal
neurons treated with TSA from 48 to 96 hours. Neurons were stained
with antibodies against MAP2 and Tau-1 to define the somatodendritic
and axonal compartments. Scale bar = 50 mm. (B) Percentage of 2 DIV
neurons that develop an axon, when treated with TSA (100 or 200 nM)
from 5 hours to 48 hours. Data represent the mean 6 SEM of 3
independent experiments (300 neurons/experimental condition and
experiment). *p,0.05, **p,0.01, paired t-test. (C) Mean axon length of
4 DIV hippocampal neurons treated with TSA (100 or 200 nM) from 48
to 96 hours. Data represent the mean 6 SEM of 3 independent
experiments (100 neurons/experimental condition and experiment).
*p,0.05, paired t-test.
doi:10.1371/journal.pone.0012908.g001
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HDAC6 inhibition or suppression delays axon formation
and decreases elongation
Then, we studied whether the effects of TSA in axonal growth
could be due to HDAC6 inhibition. To inhibit HDAC6 activity
we used tubacin, a highly specific inhibitor of HDAC6 that does
not affect the level of histone acetylation or patterns of gene-
expression [34]. As a control, we used neurons treated with
DMSO, the vehicle, or with niltubacin, an inactive derivate of
tubacin [34]. Tubacin treatment clearly inhibited HDAC6,
increasing the levels of acetylated tubulin, while niltubacin did
not affect tubulin acetylation (Figure 3A and Figure S1). To assess
the effect of HDAC6 inhibition on axonal growth, low density
cultures of neurons were exposed to tubacin from 5 hours after
plating to 2 DIV (Figure 3B), or from 2 DIV after plating to 4
DIV (Figure 3C). Our results show that a significant percentage
of neurons treated from 5 hours in vitro with 10 mM tubacin
(43.0865.05%) were unable to elongate an axon (a tau-1 positive
process), while 70.7564.77% of control neurons developed an
axon (Figure 3B). By contrast, exposing neurons to niltubacin
(10 mM) did not affect axon growth, which was similar to that in
control neurons (69.1763.95%, Figure 3B). To determine
whether inhibiting HDAC6 stopped or slowed down axon
growth, tubacin or niltubacin were added to neurons that had
previously developed an axon. After 48 hours in vitro, the mean
length of the axon in control neurons was 102.1565.86 m mm
(Figure 3C) and after 2 additional days in vitro, their axons
had reached a length of 295.4561.47 mm. When maintained
from 2 DIV to 4 DIV in the presence of 10 mM tubacin, the
mean length of the axon developed by the neurons fell to
212.45614.6 mm. Treatment with 10 mM niltubacin did not
affect the rate of axon growth that had a mean length of
297.79644.49 mm (Figure 3C).
Figure 2. HDAC6 localizes to axons and it is distributed in the distal region of axons during elongation. (A) Axonal localization of
HDAC6 (green) during axon elongation, where the axon is identified as the tau-1 (red) positive process. Arrows indicate neuronal soma position and
arrow heads the axon. Scale bar = 50 mm. (B) Fluorescence intensity along the axons of neurons (a, b and c) shown in A. HDAC6 intensity is shown in
colour lines and their respective tau-1 intensities in black lines. (C) Distal region of the axon and growth cone of a 1.5 DIV hippocampal neuron
stained for HDAC6 (green), F-actin (red) and acetylated-a-tubulin (blue). Scale bar = 50 mm. (D) 3 DIV neuron treated with cytochalasin D from 1 to 3
DIV and stained for Tau-1 and HDAC6. (E) Western-blot of 3 DIV cultured hippocampal neurons and human HDAC6-Flag transfected N2a cells. Mouse
and human HDAC6 were detected using the same antibody that the one used for immunocytochemistry (panel A). Note the difference in molecular
weight between human and mouse HDAC6.
doi:10.1371/journal.pone.0012908.g002
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To fully confirm our pharmacological experiments we analyzed
axonal growth and elongation in the absence of HDAC6. Due to
the relative low percentage of neurons that can be nucleofected,
we first checked that two different interference shRNAs against
HDAC6 can reduce endogenous HDAC6 expression in Neuro-2a
cells (Figure 4A), and that a HDAC6 shRNA can reduce
exogenous HDAC6-Flag expression in Neuro-2a cells (Figure 4B).
HDAC6 shRNAs reduced endogenous HDAC6 expression
approximately a 50% (Figure 4A), and also the expression of
exogenous HDAC6-Flag (Figure 4B), increasing the levels of
acetylated-a-tubulin in Neuro-2a cells and neurons (Figure 4B and
Figure S1).
Next, we nucleofected hippocampal neurons with plasmids
expressing two shRNAs against HDAC6, a scramble shRNA and
GFP, in order to confirme the role of HDAC6 in axonal growth.
After 3 days, we stained neurons with the tau-1 antibody
(Figure 4C) and we quantified axonal length (Figure 4D and
4E). HDAC6 expression was reduced in neurons nucleofected with
shRNA HDAC6 and absent from axons (Figure S2). Neurons
nucleofected with plasmids expressing GFP or scramble shRNA
had a mean 6 s.e.m. axonal length of 339.25611.81 mm or
326.9069.61 mm, respectively. In the case, of neurons nucleo-
fected with HDAC6 shRNA 1 or HDAC6 shRNA 2, axonal
length was significantly reduced to 221.3368.11 mm and
263.9969.21 mm, respectively (Figure 4C, 4D and 4E). In parallel
to shRNA experiments, we nucleofected neurons with HDAC6-
GFP or a non-active form of HDAC6 (HDAC6-H216A/H611A-
GFP), mutated in both deacetylase domains. HDAC6-GFP
location did mimic that of endogenous HDAC6 (Figure S3) and
was localized in axon with a distal gradient, as previously shown
for endogenous HDAC6. However, the non-active HDAC6-GFP
was homogenously distributed along the axon and HDAC6
gradient along the axon was lost (Figure S3). HDAC6-GFP
expression did not change axonal length compared to GFP
expressing neurons, while the expression of the mutated HDAC6-
GFP reduced axonal length in the same proportion as tubacin or
HDAC6 shRNAs (Figure S3).
Moreover, we tested the effect of interfering with HDAC6 in a
model of dibutyryl-cAMP (db-cAMP) induced neuritogenesis in
N2a cells (Figure S4). N2a cells expressing HDAC6 shRNA showed
a significant lower percentage of differentiation (neurite extension)
in the presence of 1 mM db-cAMP (25.0664.57%), compared to
N2a cells transfected with the GFP control plasmid (36.1361.99%)
(Figure S4). In parallel, we measured the percentage of N2a cells
differentiating when expressing HDAC6-GFP or the non-active
HDAC6-GFP mutant (Figure S4). Confirming the results obtained
with the HDAC6 shRNA constructs, there was a significative
reduction in the percentage of N2a cells differentiating in the
presence of db-cAMP when expressing the non-active HDAC6-
GFP mutant (35.6567.85%) compared to control N2a cells
expressing HDAC6-GFP (57.7610.4%).
Figure 3. HDAC6 activity inhibition reduces the rate of axon
elongation. (A) a-tubulin acetylation in 2 DIV hippocampal neurons
treated with the HDAC6 specific inhibitor tubacin, its non-active analog,
niltubacin, or its vehicle, DMSO (control). The graph represents the
mean 6 SEM of the acetylated-a-tubulin/a-tubulin ratio normalized to
control in 3 independent experiments. ****p,0.0001, paired t-test. (B) 2
DIV hippocampal neurons cultured in the presence of vehicle (DMSO),
the HDAC6 inhibitor (tubacin, 10 mM) and its inactive compound
(niltubacin, 10 mM). Neurons were stained for MAP2 and tau-1. Scale
bar = 100 mm. The graph represents the percentage of neurons with a
tau-1 positive process. Data represent the mean 6 SEM of 3
independent experiments (500 neurons/experimental condition and
experiment). ***p,0.001, paired t-test. (C) 4 DIV hippocampal neurons
cultured from 48 hours to 4 days in vitro in the presence of DMSO,
tubacin (10 mM) or niltubacin (10 mM), and stained as indicated in (B).
Scale bar = 100 mm. The graph represents the axonal length of control
neurons fixed at 2 DIV or 4 DIV, and of 4 DIV neurons treated from 2 DIV
to 4 DIV with tubacin or niltubacin. Data represent the mean 6 SEM of
3 independent experiments (150 neurons/experimental condition and
experiment). **p,0.01, paired t-test.
doi:10.1371/journal.pone.0012908.g003
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Inhibition or suppression of HDAC6 impairs the
concentration of voltage gated sodium channels and
ankyrinG at the axon initial segment
In view of the results indicating a role of HDAC6 in axonal
elongation, we checked whether a later step in axonal maturation,
the development of the axon initial segment was affected by
changes in microtubule characteristics.
Then, we studied whether tubulin deacetylases, and particularly
HDAC6, could affect the localization of important proteins for AIS
constitution and function, such as, ankyrinG and voltage gated
sodium channels. The AIS starts to form from the beginning of axon
growth [15] and it can be considered to be mature as a filter for
cytoplasmic traffic at 5 DIV [17]. Thus, cultured hippocampal
neurons were exposed to 100 or 200 nMTSA from 3 DIV to 6 DIV.
Neurons treated with TSA showed a loss of ankyrinG and sodium
channels concentration at the AIS (Figure 5A and 5B). Indeed, TSA
reduced the proportion of neurons in which ankyrinG concentrated
at the AIS from 80.0162.73% in control neurons, to 22.1962.27%
and 10.5862.32%, in the presence of 100 or 200 nM TSA,
respectively (Figure 5B). Moreover, ankyrinG distribution was
detected along the axon (Figure 5A). Sodium channels, which are
concentrated at the AIS by ankyrinG interaction, were only
concentrated at the AIS in 39612% (100 nM TSA) or 1567%
(200 nM TSA) of these neurons when compared to the control
neurons (79613%, Figure 5A and 5B). As sodium channels
expression levels are not affected (Figure 5C), the absence of sodium
channel staining, in TSA treated neurons, can be explained by the
fact that sodium channels are diffuse and under the limit of
PanNaCh antibody detection limits.
Next, we studied whether this effect was due to HDAC6
inhibition. First, we treated 3 DIV hippocampal neurons with
10 mM tubacin until 6 DIV. Control neurons showed concentrat-
ed voltage gated sodium channels and ankyrinG at the AIS in
88.1665.76% and 76.9964.93%, respectively (Figure 5D and
Figure 4. Suppression of HDAC6 by interference shRNAs reduces axonal elongation in hippocampal neurons. (A) Endogenous HDAC6
in N2a cells is suppressed by the expression of two different HDAC6 shRNAs. Graph represents the mean and SEM of HDAC6 expression levels
normalized to b-actin levels in 3 different experiments. ***p,0.001, paired t-test. (B) HDAC6 shRNA suppresses the expression of exogenous HDAC6-
Flag in N2a cells and increases acetylated-a-tubulin expression. Graph represents the reduction in HDAC6 expression in N2a cells measured with the
anti-Flag antibody. Data represent the mean and SEM of 3 independent experiments. ****p,0.0001, ***p,0.001, paired t-test. (C) 3 DIV hippocampal
neurons nucleofected with GFP plasmids expressing HDAC6 interference RNAs or scramble shRNA. Neurons were stained with anti-Tau-1 antibody to
identify the axon. Scale bar = 100 mm. (D) Quantification of the mean axonal length of 3 DIV hippocampal neurons nucleofected with the GFP
plasmids expressing GFP, scramble shRNA, HDAC6 shRNA 1 or HDAC6 shRNA 2. (E) Box-plot shows the axonal length distribution of neurons
quantified in D. ***p,0.001, paired t-test.
doi:10.1371/journal.pone.0012908.g004
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Figure 5. HDAC6 inhibition or suppression interfere the concentration of ankyrinG and voltage dependent sodium channels at the
axon initial segment. (A) Control or TSA treated 6 DIV hippocampal neurons stained with the somatodendritic marker, MAP2 (red), and the AIS
markers, ankyrinG or PanNaCh (green). Control neurons concentrate ankyrinG and sodium channels in the AIS, while in TSA treated neurons ankyrinG
staining is distributed all along the axon, and voltage gated sodium channels staining is very low or lost. Arrow head indicate the position of the
axon. Scale bar = 50 mm. (B) Percentage of neurons with ankyrinG or voltage gated sodium channels concentrated in the AIS. Data represent the
mean 6 SEM of 3 independent experiments (500 neurons/experimental condition and experiment). ***p,0.001, ****p,0.0001, paired t-test. (C)
Western-blot shows the expression levels of the a-subunit of voltage gated sodium channels in control and 100 nM TSA treated neurons compared
to b-actin expression levels. (D) 6 DIV hippocampal neurons treated with DMSO, tubacin or niltubacin from 3 DIV to 6 DIV, and then stained for MAP2
(red) and ankyrinG or sodium channels (green). (E) Percentage of neurons that show a localized concentration of ankyrinG or sodium channels at the
axon initial segment. The graphs represent the mean 6 SEM of 3 independent experiments (600 neurons/experimental condition and experiment).
*p,0.05, paired t-test. Scale bar = 100 mm. (F) 3 DIV hippocampal neurons nucleofected with an HDAC6 shRNA plasmid or the control plasmid. After 3
days in culture, neurons were stained for ankyrinG and the neuronal morphology was distinguished by GFP fluorescence. Rectangles indicate the
magnified zone shown in lower panels. Lower panels show a magnification of both neurons along the axon with ankyrinG concentrated at the initial
region of the axon (control neurons, pGFP-V-RS) or along the axon (pGFP-V-RS-shRNA-HDAC6 nucleofected neurons). Scale bar = 100 mm. (G) 3 DIV
hippocampal neurons nucleofected as in E and stained with an anti-PanNaCh antibody. Square inserts show a magnification of both neurons at the
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5E). Exposure to 10 mM tubacin reduced the number of neurons
in which sodium channels concentrated at the AIS to
65.1968.89% (Figure 5D and 5E). The concentration of
AnkyrinG at the AIS was also affected and only 56.4764.94%
of neurons treated with 10 mM tubacin concentrated ankyrinG in
this domain. AnkyrinG staining was also diffuse along the axon, as
above shown in TSA treated neurons. Niltubacin (10 mM)
treatment did not change ankyrinG or sodium channels
distribution (Figure 5D and 5E).
Finally, we analyzed AIS proteins distribution after suppression
of HDAC6 expression. As previously described, neurons were
nucleofected with scramble or HDAC6 shRNAs, as well as, the
control plasmid. Neurons were cultured for 3 days and the
percentage of neurons that concentrated sodium channels and
ankyrinG at the AIS was analyzed (Figure 5F-I). Only
48.4162.2% and 42.7262.99% of HDAC6 interference RNA 1
or 2 nucleofected neurons showed a concentration of ankyrinG at
the AIS. In the same experiments, only 38.6663.47% and
48.8364.02% of neurons nucleofected with HDAC6 interference
RNA 1 or 2 had a concentration of sodium channels at the AIS.
Control or scramble shRNA nucleofected neurons showed higher
percentage of neurons with concentrated ankyrinG at the AIS
(66.7264.87, in control neurons, and % 64.2963.87% in shRNA
scramble neurons) and sodium channels (63.6263.78, in control
neurons, and % 65.0161.69%, in shRNA scramble neurons). The
reduced concentration of ankyrinG due to HDAC6 interference
expression was associated with an ankyrinG staining along the
axon (Figure 5F), similar to that produce by tubacin or TSA
treatment.
Tubulin deacetylases participate in maintaining specific
characteristics of axon initial segment microtubules
HDAC6 inhibition or suppression impairs the tethering of AIS
proteins; nevertheless HDAC6 is not localized at the axon initial
segment in any analyzed stage from 1 to 15 DIV (Figure 2A and
unpublished data). In order to understand the mechanism by
which HDAC6 inhibition or suppression affects axon initial
segment proteins concentration at the AIS, we analyzed whether
the HDAC6 presence at the distal region of the axon and its
absence from the axon initial segment could confer these
microtubules different characteristics compared to microtubules
at the axon initial segment. Thus, we analyzed whether AIS
microtubules characteristics were different from the rest of the
axon. AIS contained proteins are characterized by their resistance
to detergent extraction [15,16,18]. In fixed 7 DIV neurons
(Figure 6C), acetylated tubulin was distributed throughout the
neuron, but when neurons were treated with non-ionic detergent
(TX-100) prior to fixation, acetylated tubulin was essentially
restricted to the AIS and co-localized with a marker of the axon
initial segment, pIkBa (Figure 6D, 6F and 6G). This restriction of
acetylated microtubules to the AIS was eliminated when 7 DIV
hippocampal neurons were treated with 100 nM TSA during
48 hours prior to extraction, and acetylated-a-tubulin staining was
homogeneously distributed all along the axons (Figure 6E–G). At
the same time, pIkBa staining was not concentrated and under
detection limits of the antibody (Figure 6E). We confirmed by
western-blot that TSA had significantly increased the levels of
acetylated-a-tubulin in the non-extracted resistant microtubules
(Figure 6A and 6B).
The lack of HDAC6 activity alters the KIF5C overall
distribution along the neuron
Acetylated tubulin is also related to protein transport and serves
as an interaction point for kinesins. Kinesin-1 has been related
with axonal growth, axon initial segment, and with acetylated
tubulin. Thus, we checked whether microtubules modifications
due to the absence of HDAC6 could affect the location of the
molecular motor, KIF5C. First, we treated 3 DIV hippocampal
neurons with 100 nM TSA and analyzed the distribution of
KIF5C at 6 DIV. While KIF5C staining was mainly detected in
the distal region of the axon in 89.5362.28% of control neurons,
only 29.0062.07% of TSA treated neurons presented a clear
axonal distal gradient of KIF5C (Figure 7A and 7B). The
modification of KIF5C axonal gradient was characterized by a
homogeneous staining along the axon and a somato-dendritic
staining of KIF5C, associated to an increased tubulin acetylation
in both domains (Figure 7A and 7B). However, TSA treatment did
not impede KIF5C localization at axonal growth cones (Figure 7A).
Concomitantly, after HDAC6 suppression KIF5C axonal gradient
in 4 DIV neurons was only observed in around a 55% of neurons
compared to scramble shRNA nucleofected neurons (Figure 7C
and D). Regarding HDAC6 function, KIF5C was polarized to the
axon in 75.5361.07% of HDAC6-GFP nucleofected neurons,
while only 49.763.29% of non-active HDAC6-GFP presented an
axonal polarization of KIF5C (Figure 7E and 7F). Both, after
suppression of HDAC6 or the expression of the non-active
HDAC6, KIF5C was also observed at axonal tips, clearly
augmented in the somatodendritic domain and homogeneously
distributed along the axon.
These results suggest that the reduction in axonal growth due to
HDAC6 suppression can be related, in some degree, to the altered
distribution of motor proteins, after modification of microtubules
domains along the axon.
Discussion
HDAC6 has been involved in multiple regulatory events related
to development or disease, interacting with different proteins.
Thus, it is possible that HDAC6 could have different functions in
different developmental stages and different physiological or
pathological conditions. While HDAC6 function during brain
development has not been extensively studied, HDAC6 has an
important role in the regulation of mechanisms related with
different neurodegenerative diseases in adult brain. HDAC6
ubiquitin binding activity is necessary for the recruitment of
autophagic material to aggresomes and its degradation by
proteasome [35]. HDAC6 is necessary for the degradation of
aggregated hungtingtin [36], regulates the traffic of parkin, a
Parkinson linked protein [37], and also HDAC6 mRNA levels are
significantly decreased in bipolar disorder patients [24].
We have focussed our study in the role of HDAC6 during the
first stages of axonal growth in hippocampal neurons. Our data
show a role for HDAC6 during the initial development of axons,
where HDAC6 is necessary for axonal elongation and the
development of the axonal initial segment. In this developmental
context and based in our observations, we believe that HDAC6
localization at the distal region of the axon regulate microtubules
characteristics in this region, at least through its deacetylase
domains. Our data show that the absence of HDAC6 activity in
level of the AIS. Scale bar = 100 mm. (H, I) Percentage of GFP, scramble shRNA or HDAC6 shRNAs nucleofected neurons that concentrate ankyrinG (G)
or sodium channels (H) in the AIS after 3 days in culture. Data are the mean 6 SEM of 3 independent experiments (100 neurons/experimental
condition and experiment). * p,0.05, **p,0.01, t-test.
doi:10.1371/journal.pone.0012908.g005
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hippocampal neurons, due to pharmacological inhibition or to the
genetic targeted elimination of HDAC6, slows down axonal
growth and generates an overall increased tubulin acetylation. It
has been previously reported in non-neuronal cells that HDAC6
inhibition can reduce microtubule growth velocity [25]. The
authors propose that this reduction is independent of microtubules
acetylation generated by HDAC6 inhibition, and may be the
result of the generation of a ‘‘leaky cap’’ at the plus-end of
microtubules, impeding both attachment and detachment of
tubulin subunits [25]. From our data we can conclude that
Figure 6. Tubulin deacetylase inhibition disrupts the axon initial segment specific enrichment in detergent resistant acetylated
microtubules. (A) Acetylated-a-tubulin levels in microtubules resistant to PHEM buffer extraction in control and TSA treated neurons. (B) Graph
represents the mean 6 SEM of a-tubulin acetylation levels from 3 experiments as indicated in A. **p,0.01, *** p,0.001, t-test. (C) Acetylated-a-
tubulin expression in 7 DIV hippocampal neurons. Axon initial segment is stained with the pIkBa antibody. (D) 7 DIV hippocampal neurons fixed after
extraction with 0.5% Triton X-100 in cytoskeletal buffer (2 mM MgCl2, 10 mM EGTA, 60 mM Pipes pH 7.0) for 5 min at 37uC. Arrows indicate the axon
initial segments, stained with acetylated-a-tubulin (red) and pIkBa (green). Box shows an amplification of the indicated axon initial segment. (E)
Acetylated-a-tubulin localization in 100 nM TSA treated neurons extracted as indicated in D. Note that acetylated tubulin is not further restricted to
the AIS and located along the axon. (F) Acetylated-a-tubulin and total a-tubulin immunostaining of control or 100 nM TSA treated neurons extracted
with 0.5% Triton X-100. Arrows indicate the position of neuronal somas. (G) Graph represents the fluorescence intensity of acetylated-a-tubulin (red
lines) and a-tubulin (green lines) along the stained axon in control (dotted lines) and TSA (straight lines) treated neurons shown in F. Intensity lines
are the result of smoothing the data obtained with the ImageJ program using the Sigmaplot software.
doi:10.1371/journal.pone.0012908.g006
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Figure 7. The absence of HDAC6 activity alters the distribution of KIF5C along the neuron. (A) KIF5C localization and acetylated-a-tubulin
staining in 6 DIV hippocampal neurons cultured in the absence of TSA, or treated with 100 nM TSA from 3 to 6 DIV. Scale bar = 100 mm. (B)
Percentage of neurons with a KIF5C with a main axonal localization as shown in A (control neuron). **p,0.01 (t-test). (C) KIF5C localization in 4 DIV
hippocampal neurons nucleofected before plating with HDAC6 interference shRNA or scramble. GFP fluorescence indicates the nucleofected
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HDAC6 activity is necessary for axonal growth, however we can
not exclude that in neurons the increased acetylation due to
HDAC6 inhibition can play an important role in neuronal
development. One important difference between non-neuronal
cells and neurons is the expression of Tau, an important regulator
of HDAC6 [38]. In fact, our results show that HDAC6 colocalizes
in neurons with acetylated microtubules and with Tau. A recent
study has pointed that the ratio between acetylated tubulin versus
tyrosinated tubulin is higher in the neurite specified as axon [6].
Thus, an increment of acetylated tubulin levels in all the neurites
after HDAC6 inhibition could explain the lack of axonal growth
due to the lost of polarized distribution of acetylated versus
tyrosinated tubulin ratio at the neurite previously specified as
axon, and the subsequent absence of polarized axonal traffic. Our
data show that the sustained inhibition of HDAC6 or its
suppression during axonal growth, increases microtubules acety-
lation and modifies the overall distribution of at least a motor
protein, KIF5C, which is one of the first proteins to be present in
the axon growth cone during initial neuronal polarization [13] and
has also been found to co-localize with microtubules at the axon
initial segment [14]. Our data are supported by the fact that
treatment of neurons with taxol, that increases tubulin acetylation,
generates a non polarized distribution of kinesin-1 [14,39]. The
same study shows that TSA or tubacin treatment for short times
(around 3 hours) did not modify exogenous kinesin-1 localization
[39]. However, we show that a sustained inhibition of HDAC6
with TSA or tubacin (during at least 48 hours) did altere the
distribution of endogenous KIF5C along the neuron without
impairing KIF5C arrival to growth cones. In fact, a rise in
microtubule acetylation due to HDAC6 inhibition increases the
binding of kinesin-1 and their transport speed [12] and generates a
non-polarized distribution of JIP, an interacting protein of kinesin-
1. Two recent studies have shown that kinesin-1 family members,
KIF5B or KIF5C, bind and navigate preferentially on detyrosi-
nated tubulin and on acetylated microtubules [10,11].
HDAC6 has different functional domains, two deacetylase
domains and an ubiquitin binding domain. Impaired function of
HDAC6 also reduces dendrites length by a mechanism involving
ubiquitin binding domain. HDAC6 binds Cdc20 and is necessary
for the polyubiquitination of Cdc20, which stimulates the activity
of centrosomal Cdc20-APC complex promoting the degradation
of Id1, and drives the differentiation of dendrites [23]. The Cdc20-
APC complex has not been localized in axons and is located at the
centrosome, structure that is not necessary for axonal elongation
[40]. It is possible that HDAC6 can regulate axon growth and
dendrite growth forming different complexes in different subcel-
lular locations. Our observations demonstrate a role of the
HDAC6 deacetylase activity in the regulation of axon develop-
ment, and inhibition of HDAC6 deacetylase or HDAC6
suppression has a similar effect in axonal growth reduction.
Moreover, we have shown that HDAC6 co-localizes with the Tau-
1 marker at the axon, and HDAC6 interaction with Tau can
change Tau phosphorylation [30]. Tau is a neural specific protein
not expressed in other non-neuronal cells, what may explain
differences observed between neuronal and non-neuronal cells
studies of HDAC6. The co-localization of HDAC6 and Tau-1 in
the more dynamic domain of the axon suggest a role of both
proteins in promoting the microtubules cytoskeleton characteris-
tics necessary for axonal growth and transport. In fact, Tau can
inhibit HDACs activity and is necessary for the binding of
HDAC6 to microtubules [38]. Tau also binds to the dynactin
complex and this interaction promotes the attachment of the
complex to microtubules [41]. Interestingly, HDAC6 also interacts
with the dynactin complex [35], and so it can regulate protein
transport to the axon. The phosphatase PP1 has also been found in
a complex with HDAC6 [42]. PP1 is recruited to microtubules by
Tau, dephosphorylates Tau in other epitopes and also other MAPs
and plays a role in the regulation of microtubules [43]. Thus, it is
possible that HDAC6 activity may be regulated by MAPs, or can
regulate the interaction of MAPs with microtubules. In this sense,
an important regulator of MAPs, GSK3, interacts and activates
HDAC6 deacetylase activity [44]. Interestingly, GSK3 inhibition
decreases HDAC6 activity [44], but also is able to impair axon
formation [45].
Under pathological conditions, HDAC6 may play a function in
neuronal regeneration under restrictive conditions for axonal
growth, and it has been proposed that HDAC6 inhibition can
partially neutralize the inhibitory effects of myelin associated
glycoprotein (MAG) in the initial growth of cortical neurons
neurites [46]. However, our data show that HDAC6 activity is
necessary for the initial development of the axon in hippocampal
neurons in conditions where glial cells are not present or their role
is reduced, as it happens in early development. One plausible
explanation is that, in conditions where MAG is activating
receptors and signaling proteins, HDAC6 plays another role
coupling the MAG signaling to microtubules. HDAC6 inhibition
could then abolish the MAG negative effect in neurites growth. In
fact, it has been described in podosomes that increased Rho
activity can significantly increase HDAC6 deacetylase activity
[47].
Regarding the involvement of HDAC6 in the regulation of the
axon initial segment (AIS), a highly important structure for the
axonal identity and neuronal function [16,48], we show that the
AIS microtubules resistant to detergent extraction are highly
acetylated. Previous studies have shown that microtubules in
different axonal regions have different post-translational modifi-
cations [8,49]. This specificity of AIS microtubules is disrupted by
HDAC6 inhibition, which increases acetylation of microtubules all
along the axon and confers the property of detergent extraction
resistance to these microtubules. Thus, proteins that are allocated
to the AIS, such as ankyrinG, change their distribution along the
axon after HDAC6 inhibition or suppression, allowing other
ankyrinG interacting proteins, such as voltage gated sodium
channels to diffuse along the axon. So therefore, this disorganized
distribution of AIS proteins can be due to the lack of specific
microtubules domains, which modify the directional transport of
kinesin-1, and do not allow the concentration of proteins at the
AIS.
In conclusion, the distribution of HDAC6 in the distal region of
the axon and its absence from the proximal region of the axon
may regulate the formation of different microtubules domains in
the axon. HDAC6 regulated activity at the distal axon can
promote axonal growth, while microtubules at the proximal region
of the axon can be more acetylated and allow the maintenance of
the axon initial segment, necessary for polarized axonal traffic,
tethering of AIS proteins and generation of neuronal action
neurons. (D) Percentage of scramble or HDAC6 interference shRNA nucleofected neurons with a KIF5C with a main axonal localization. *p,0.05 (t-
test). (E) KIF5C localization in 3 DIV HDAC6-GFP or HDAC6 non-active mutant nucleofected neurons. (F) Percentage of neurons showing a KIF5C with
a main axonal localization in neurons expressing HDAC6-GFP or an HDAC6-GFP non-active mutant. **p,0.01 (t-test). All data represent the mean 6
SEM of three experiments and at least 100 neurons by condition and experiment.
doi:10.1371/journal.pone.0012908.g007
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potentials. Further experiments will be necessary to understand
how HDAC6 deacetylase activity is regulated at the axon.
Supporting Information
Figure S1 HDAC6 inhibition and suppression increases tubulin
acetylation in cultured hippocampal neurons. (A) 4 DIV
hippocampal neurons treated with DMSO (control), TSA
100 nM or tubacin 10 mM, and stained for acetylated-a-tubulin.
Note an increased gradient towards the growth cone in DMSO
neurons that is not observed in TSA or tubacin treated neurons.
Scale bar = 100 mm. (B) a-tubulin acetylation levels in cellular
extracts of control neurons and neurons treated with TSA for
24 hours. (C) Fluorescence intensity of acetylated-a-tubulin along
the axons of neurons treated as indicated in A. Graph represents
the mean 6 S.E.M. of acetylated-a-tubulin fluorescence intensity
obtained from 5 neurons in each experimental condition. Each
point represents the added fluorescence intensity of every 20 mm.
(D) 4 DIV hippocampal neurons nucleofected with GFP plasmids
expressing scramble or HDAC6 interference RNA. Neurons were
stained with acetylated-a-tubulin (red). Scale bar = 100 mm. (E)
Fluorescence intensity of acetylated-a-tubulin along the axon in
neurons nucleofected with scrambled or HDAC6 interference
RNA 1 or 2. Fluorescence intensity of acetylated-a-tubulin along
the axons of neurons treated as indicated in A. Graph represents
the mean 6 S.E.M. of acetylated-a-tubulin fluorescence intensity
obtained from 5 neurons in each experimental condition. Each
point represents the added fluorescence intensity of every 20 mm.
Found at: doi:10.1371/journal.pone.0012908.s001 (2.10 MB TIF)
Figure S2 Quantification of HDAC6 expression levels in
scramble shRNA and HDAC6 shRNA nucleofected neurons. (A)
HDAC6 expression and DIC images of scramble shRNA and
HDAC6 shRNA nucleofected neurons. Arrows indicate the soma
of nucleofected neuron and arrowheads indicate the axon. Scale
bar = 50 mm. (B) Fluorescence intensity of HDAC6 along the
axon in the neurons shown in A. (C) Normalized HDAC6
expression in axons of 50 neurons nucleofected with scramble
shRNA or HDAC6 shRNA 1. ***p,0.001, paired t-test.
Found at: doi:10.1371/journal.pone.0012908.s002 (3.23 MB TIF)
Figure S3 Non-active HDAC6-GFP reduces axonal growth. (A)
3 DIV hippocampal neurons nucleofected with HDAC6-GFP or
non-active HDAC6-GFP plasmids and stained for tau-1. Scale bar
= 100 mm. (B) Mean axon length of the neurons shown in B,
nucleofected with GFP, HDAC6-GFP or non-active HDAC6-
GFP. Data represent the mean 6 SEM of 3 independent
experiments (100 GFP positive neurons/experimental condition
and experiment). **p,0.01, paired t-test. (C) 4 DIV hippocampal
neurons nucleofected with HDAC6-GFP or non-active HDAC6-
GFP. Neurons were stained with anti-HDAC6 antibody (red).
Note the colocalization of exogenous expressed HDAC6-GFP
(green) and endogenous HDAC6 (red). Scale bar = 100 mm.
Found at: doi:10.1371/journal.pone.0012908.s003 (1.88 MB TIF)
Figure S4 HDAC6 impaired function interfere with N2a cells
differentiation. (A) N2a cells transfected with pGFP-V-RS or
pGFP-V-RS-shHDAC6 and differentiated for 2 days with 1 mM
dibutyryl-cAMP. Transfected cells were identified by the GFP
fluorescence and their morphology was determined staining cells
for tyrosinated-a-tubulin. (B) Quantification of the percentage of
GFP positive differentiated N2a cells transfected with the pGFP-
V-RS or pGFP-V-RS-shHDAC6 plasmids. Data represent the
mean and SEM of 3 independent experiments (200 GFP positive
cells/experimental condition and experiment). *p,0.05, paired t-
test. (C) N2a cells transfected with HDAC6-GFP or mutant non-
active HDAC6-GFP and differentiated for 2 days with 1 mM
dibutyryl-cAMP. Transfected cells were identified by the GFP
fluorescence and their morphology was determined staining cells
for tyrosinated-a-tubulin. (D) Percentage of GFP positive differ-
entiated N2a cells transfected with the HDAC6-GFP or non-active
HDAC6-GFP plasmids. Data represent the mean and SEM of 3
independent experiments (200 GFP positive cells/experimental
condition and experiment). **p,0.01, t-test.
Found at: doi:10.1371/journal.pone.0012908.s004 (1.87 MB TIF)
Acknowledgments
We thank R. Mazitschek and the ICG (Initiative for Chemical Genetics-
National Cancer Institute) for providing us with tubacin and niltubacin, F.
Sanchez-Madrid for HDAC6-GFP plasmids and J. Diaz-Nido for critical
reading.
Author Contributions
Conceived and designed the experiments: MT FGW JJG. Performed the
experiments: MT. Analyzed the data: MT FGW JJG. Wrote the paper:
JJG.
References
1. Conde C, Caceres A (2009) Microtubule assembly, organization and dynamics
in axons and dendrites. Nat Rev Neurosci 10: 319–332.
2. Hammond JW, Cai D, Verhey KJ (2008) Tubulin modifications and their
cellular functions. Curr Opin Cell Biol 20: 71–76.
3. Verhey KJ, Gaertig J (2007) The tubulin code. Cell Cycle 6: 2152–2160.
4. Westermann S, Weber K (2003) Post-translational modifications regulate
microtubule function. Nat Rev Mol Cell Biol 4: 938–947.
5. Creppe C, Malinouskaya L, Volvert ML, Gillard M, Close P, et al. (2009)
Elongator controls the migration and differentiation of cortical neurons through
acetylation of alpha-tubulin. Cell 136: 551–564.
6. Witte H, Neukirchen D, Bradke F (2008) Microtubule stabilization specifies
initial neuronal polarization. J Cell Biol 180: 619–632.
7. Ahmad FJ, Pienkowski TP, Baas PW (1993) Regional differences in microtubule
dynamics in the axon. J Neurosci 13: 856–866.
8. Baas PW, Ahmad FJ, Pienkowski TP, Brown A, Black MM (1993) Sites of
microtubule stabilization for the axon. J Neurosci 13: 2177–2185.
9. Baas PW, Black MM (1990) Individual microtubules in the axon consist of
domains that differ in both composition and stability. J Cell Biol 111: 495–509.
10. Dunn S, Morrison EE, Liverpool TB, Molina-Paris C, Cross RA, et al. (2008)
Differential trafficking of Kif5c on tyrosinated and detyrosinated microtubules in
live cells. J Cell Sci 121: 1085–1095.
11. Konishi Y, Setou M (2009) Tubulin tyrosination navigates the kinesin-1 motor
domain to axons. Nat Neurosci 12: 559–567.
12. Reed NA, Cai D, Blasius TL, Jih GT, Meyhofer E, et al. (2006) Microtubule
acetylation promotes kinesin-1 binding and transport. Curr Biol 16: 2166–2172.
13. Jacobson C, Schnapp B, Banker GA (2006) A change in the selective
translocation of the Kinesin-1 motor domain marks the initial specification of
the axon. Neuron 49: 797–804.
14. Nakata T, Hirokawa N (2003) Microtubules provide directional cues for
polarized axonal transport through interaction with kinesin motor head. J Cell
Biol 162: 1045–1055.
15. Sanchez-Ponce D, Tapia M, Munoz A, Garrido JJ (2008) New role of IKK
alpha/beta phosphorylated I kappa B alpha in axon outgrowth and axon initial
segment development. Mol Cell Neurosci 37: 832–844.
16. Garrido JJ, Giraud P, Carlier E, Fernandes F, Moussif A, et al. (2003) A
targeting motif involved in sodium channel clustering at the axonal initial
segment. Science 300: 2091–2094.
17. Song AH, Wang D, Chen G, Li Y, Luo J, et al. (2009) A selective filter for
cytoplasmic transport at the axon initial segment. Cell 136: 1148–1160.
18. Winckler B, Forscher P, Mellman I (1999) A diffusion barrier maintains
distribution of membrane proteins in polarized neurons. Nature 397: 698–
701.
19. Hubbert C, Guardiola A, Shao R, Kawaguchi Y, Ito A, et al. (2002) HDAC6 is a
microtubule-associated deacetylase. Nature 417: 455–458.
20. North BJ, Marshall BL, Borra MT, Denu JM, Verdin E (2003) The human Sir2
ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol Cell 11:
437–444.
21. Pandithage R, Lilischkis R, Harting K, Wolf A, Jedamzik B, et al. (2008) The
regulation of SIRT2 function by cyclin-dependent kinases affects cell motility.
J Cell Biol 180: 915–929.
HDAC6 and Axon Development
PLoS ONE | www.plosone.org 12 September 2010 | Volume 5 | Issue 9 | e12908
22. Southwood CM, Peppi M, Dryden S, Tainsky MA, Gow A (2007) Microtubule
deacetylases, SirT2 and HDAC6, in the nervous system. Neurochem Res 32:
187–195.
23. Kim AH, Puram SV, Bilimoria PM, Ikeuchi Y, Keough S, et al. (2009) A
centrosomal Cdc20-APC pathway controls dendrite morphogenesis in postmi-
totic neurons. Cell 136: 322–336.
24. Hobara T, Uchida S, Otsuki K, Matsubara T, Funato H, et al. (2009) Altered
gene expression of histone deacetylases in mood disorder patients. J Psychiatr
Res.
25. Zilberman Y, Ballestrem C, Carramusa L, Mazitschek R, Khochbin S, et al.
(2009) Regulation of microtubule dynamics by inhibition of the tubulin
deacetylase HDAC6. J Cell Sci 122: 3531–3541.
26. Gao YS, Hubbert CC, Lu J, Lee YS, Lee JY, et al. (2007) Histone deacetylase 6
regulates growth factor-induced actin remodeling and endocytosis. Mol Cell Biol
27: 8637–8647.
27. Pugacheva EN, Jablonski SA, Hartman TR, Henske EP, Golemis EA (2007)
HEF1-dependent Aurora A activation induces disassembly of the primary
cilium. Cell 129: 1351–1363.
28. Zhang X, Yuan Z, Zhang Y, Yong S, Salas-Burgos A, et al. (2007) HDAC6
modulates cell motility by altering the acetylation level of cortactin. Mol Cell 27:
197–213.
29. Matsuyama A, Shimazu T, Sumida Y, Saito A, Yoshimatsu Y, et al. (2002) In
vivo destabilization of dynamic microtubules by HDAC6-mediated deacetyla-
tion. Embo J 21: 6820–6831.
30. Ding H, Dolan PJ, Johnson GV (2008) Histone deacetylase 6 interacts with the
microtubule-associated protein tau. J Neurochem 106: 2119–2130.
31. Goslin K, Banker G (1989) Experimental observations on the development of
polarity by hippocampal neurons in culture. J Cell Biol 108: 1507–1516.
32. Cabrero JR, Serrador JM, Barreiro O, Mittelbrunn M, Naranjo-Suarez S, et al.
(2006) Lymphocyte chemotaxis is regulated by histone deacetylase 6,
independently of its deacetylase activity. Mol Biol Cell 17: 3435–3445.
33. Brown A, Li Y, Slaughter T, Black MM (1993) Composite microtubules of the
axon: quantitative analysis of tyrosinated and acetylated tubulin along individual
axonal microtubules. J Cell Sci 104 (Pt 2): 339–352.
34. Haggarty SJ, Koeller KM, Wong JC, Grozinger CM, Schreiber SL (2003)
Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-
mediated tubulin deacetylation. Proc Natl Acad Sci U S A 100: 4389–4394.
35. Kawaguchi Y, Kovacs JJ, McLaurin A, Vance JM, Ito A, et al. (2003) The
deacetylase HDAC6 regulates aggresome formation and cell viability in response
to misfolded protein stress. Cell 115: 727–738.
36. Iwata A, Riley BE, Johnston JA, Kopito RR (2005) HDAC6 and microtubules
are required for autophagic degradation of aggregated huntingtin. J Biol Chem
280: 40282–40292.
37. Jiang Q, Ren Y, Feng J (2008) Direct binding with histone deacetylase 6
mediates the reversible recruitment of parkin to the centrosome. J Neurosci 28:
12993–13002.
38. Perez M, Santa-Maria I, de Barreda EG, Zhu X, Cuadros R, et al. (2009) Tau -
an inhibitor of deacetylase HDAC6 function. J Neurochem.
39. Hammond JW, Huang CF, Kaech S, Jacobson C, Banker G, et al. (2010)
Posttranslational modifications of tubulin and the polarized transport of kinesin-
1 in neurons. Mol Biol Cell 21: 572–583.
40. Stiess M, Maghelli N, Kapitein LC, Gomis-Ruth S, Wilsch-Brauninger M, et al.
(2010) Axon extension occurs independently of centrosomal microtubule
nucleation. Science 327: 704–707.
41. Magnani E, Fan J, Gasparini L, Golding M, Williams M, et al. (2007)
Interaction of tau protein with the dynactin complex. Embo J 26: 4546–4554.
42. Brush MH, Guardiola A, Connor JH, Yao TP, Shenolikar S (2004) Deactylase
inhibitors disrupt cellular complexes containing protein phosphatases and
deacetylases. J Biol Chem 279: 7685–7691.
43. Liao H, Li Y, Brautigan DL, Gundersen GG (1998) Protein phosphatase 1 is
targeted to microtubules by the microtubule-associated protein Tau. J Biol
Chem 273: 21901–21908.
44. Chen S, Owens GC, Makarenkova H, Edelman DB HDAC6 regulates
mitochondrial transport in hippocampal neurons. PLoS One 5: e10848.
45. Garrido JJ, Simon D, Varea O, Wandosell F (2007) GSK3 alpha and GSK3
beta are necessary for axon formation. FEBS Lett 581: 1579–1586.
46. Rivieccio MA, Brochier C, Willis DE, Walker BA, D’Annibale MA, et al. (2009)
HDAC6 is a target for protection and regeneration following injury in the
nervous system. Proc Natl Acad Sci U S A 106: 19599–19604.
47. Destaing O, Saltel F, Gilquin B, Chabadel A, Khochbin S, et al. (2005) A novel
Rho-mDia2-HDAC6 pathway controls podosome patterning through microtu-
bule acetylation in osteoclasts. J Cell Sci 118: 2901–2911.
48. Hedstrom KL, Ogawa Y, Rasband MN (2008) AnkyrinG is required for
maintenance of the axon initial segment and neuronal polarity. J Cell Biol 183:
635–640.
49. Shea TB (1999) Selective stabilization of microtubules within the proximal
region of developing axonal neurites. Brain Res Bull 48: 255–261.
HDAC6 and Axon Development
PLoS ONE | www.plosone.org 13 September 2010 | Volume 5 | Issue 9 | e12908
